Case Details
- Citation: [2024] SGHC 239
- Title: Public Prosecutor v Iswan bin Ali
- Court: High Court of the Republic of Singapore (General Division)
- Criminal Case No: Criminal Case No 4 of 2024
- Date of Judgment: 17 September 2024
- Judge: Dedar Singh Gill J
- Plaintiff/Applicant: Public Prosecutor
- Defendant/Respondent: Iswan bin Ali
- Legal Area: Criminal Law — Statutory offences
- Statutes Referenced: Criminal Procedure Code (Cap 68, 2012 Rev Ed); Misuse of Drugs Act (Cap 185, 2008 Rev Ed)
- Key Charge: One charge of having in possession for the purpose of trafficking not less than 61.19 grams of diamorphine under s 5(1)(a) read with s 5(2) of the Misuse of Drugs Act
- Hearing Dates: 23–25, 29–31 January, 6, 8 February, 8 April 2024
- Judgment Length: 50 pages, 13,489 words
- Cases Cited (as provided): [2009] SGHC 202; [2024] SGHC 239
Summary
Public Prosecutor v Iswan bin Ali concerned a charge under the Misuse of Drugs Act (“MDA”) for possession of diamorphine for the purpose of trafficking. The case turned on whether the prosecution proved, beyond reasonable doubt, both (i) the integrity of the drug exhibits through the chain of custody, and (ii) the substantive elements of the offence, including possession, knowledge of the nature of the drugs, and the statutory presumption of trafficking.
The High Court (Dedar Singh Gill J) analysed the evidence surrounding the seizure of multiple drug exhibits from the accused’s car, the subsequent handling and storage of those exhibits at the CNB exhibit management facilities, and the weighing and forensic analysis process. The court also considered the accused’s shifting accounts and his attempt to rely on a “bailee” style defence, including an assertion that he was involved only in the sale or delivery of drugs to another person rather than trafficking in the statutory sense.
What Were the Facts of This Case?
On 9 April 2020 at about 12.45am, CNB officers raided the home of Iswan bin Ali (“Iswan”). Iswan was arrested at his unit in Block 90 Pipit Road. Shortly after the arrest, at about 12.53am, Iswan informed an officer in Malay that there were drugs kept in his car (plate number SJL6639L). CNB officers then seized a Honda car remote key from Iswan and escorted him to the carpark around 1.20am.
At about 1.25am, a search of the car was conducted in Iswan’s presence. Six packets containing granular or powdery substances were seized from different locations within the vehicle. The exhibits were marked as A1A1A, A1A2A, A1A3A, B1A1, C1A and C1B. The seized items were packed by CNB officers during the search. The search concluded at about 2.15am, after which the seized exhibits were handed over through a series of custody transfers: first to SI Sunny Tay, and then to Inspector Eng Chien Loong Eugene (“Insp Eugene”).
Later the same day, CNB officers escorted Iswan to his registered address at Block 627 Yishun Street 71. During that unit search, they seized an additional packet of crystalline substance, later marked J1A1. The judgment’s structure indicates that J1A1 became relevant to an evidential issue concerning an omission of an exhibit (notably Exhibit J1A1), although the charge in the case focused on diamorphine exhibits.
Insp Eugene retained custody of the seized exhibits until processing at the Exhibit Management Room (“EMR”) in CNB. The exhibits were processed by IO Asilah, SI Cindy Ow and members of the CNB Forensic Response Team. The court recorded that the processing ended at about 9.47am. At about 9.51am, IO Asilah and SI Cindy Ow commenced weighing of the seized drug exhibits. Iswan witnessed the weighing through a glass panel. The court set out the weights of each exhibit at the weighing stage, and then the exhibits were sealed and stored in IO Asilah’s locked cabinet at CNB HQ, with only IO Asilah having access.
At around 12.00pm, IO Asilah handed over the case exhibits to SI Cindy Ow, who submitted them to the CNB Exhibit Management Team. The exhibits were kept in a locked cabinet in the EMT office. Subsequently, the exhibits were collected for forensic analysis by an officer who brought them to the Health Sciences Authority (“HSA”). HSA issued certificates under s 16 of the MDA dated 15 May 2020, confirming that the exhibits contained diamorphine in specified quantities.
During investigations, Iswan gave multiple statements to CNB officers, including two contemporaneous statements and eight statements recorded under s 22 of the Criminal Procedure Code (“CPC”). The judgment indicates that Iswan did not challenge the voluntariness and admissibility of those statements, but sought amendments or clarifications during trial. The court also noted that psychiatric assessments were conducted on Iswan, although the excerpt provided does not show how those assessments affected the final reasoning.
What Were the Key Legal Issues?
The High Court identified several interlocking issues. The first set concerned whether the prosecution established the chain of custody of the seized drug exhibits. This included scrutiny of the removal and delivery of the exhibits from the locked cabinet, the difference in weight between the exhibits at different stages (weighing at CNB vs analysis at HSA), and an omission relating to Exhibit J1A1. These issues are critical in MDA prosecutions because any break or unexplained discrepancy in custody can undermine the inference that the accused possessed the same drugs that were later analysed and relied upon at trial.
The second set of issues concerned whether the elements of the charge were established. Under s 5(1)(a) read with s 5(2) of the MDA, the prosecution must prove possession of a controlled drug for the purpose of trafficking. The court therefore had to consider whether Iswan had possession of the seized drug exhibits, whether he had knowledge of the nature of the drugs, and whether the statutory presumption of trafficking applied on the facts.
Finally, the court addressed the accused’s defence theory. The judgment’s outline indicates that Iswan’s accounts shifted over time, and that he advanced a “bailee” defence. The defence appears to have been framed around the idea that Iswan was involved in the sale of certain exhibits to a person named Zahari and that he knew the drugs were meant to be passed on to other persons. The court also had to consider whether a “consumption” defence (ie, that the drugs were for personal consumption rather than trafficking) could apply to some of the exhibits.
How Did the Court Analyse the Issues?
The court’s analysis began with the chain of custody. In MDA cases, the prosecution must show that the exhibits seized from the accused were the same exhibits analysed by the forensic laboratory and produced in court. The judgment’s outline highlights that the court examined the evidence on how the seized drugs were removed from the car, packed, handed over between officers, and then retained and stored in secure facilities. The court also examined the custody timeline from the initial seizure at the carpark, through EMR processing, to weighing, sealing, locked storage, and later handover to the EMT and onward collection for HSA analysis.
Part of the chain-of-custody inquiry focused on the “removal and delivery” of the exhibits from the locked cabinet. The court scrutinised who had access to the locked cabinet, whether the exhibits were sealed appropriately, and whether the handover process was sufficiently documented to prevent tampering or substitution. The judgment indicates that IO Asilah had exclusive access to the locked cabinet containing the sealed exhibits, which is typically a key evidential safeguard. The court also considered the timing and manner in which custody was transferred to the EMT and then to the officer who collected the exhibits for analysis.
The court also addressed the difference in weight between the CNB weighing stage and the HSA analysis stage. Weight discrepancies can arise due to moisture loss, differences in weighing conditions, or other handling factors. The court’s approach in such cases generally requires that the prosecution provide a coherent explanation for any variance and that the variance does not create a reasonable doubt that the analysed substance was not the same as the seized substance. The judgment’s structure suggests that the court treated the weight differences as a specific chain-of-custody and evidential reliability issue, rather than a mere technicality.
In addition, the court considered the omission of Exhibit J1A1. While J1A1 was seized during the unit search, the outline indicates that there was an omission in the evidential record or exhibit management process that required judicial attention. The court’s reasoning would have assessed whether the omission was material to the integrity of the diamorphine exhibits relied upon for the charge, or whether it was an administrative gap that did not affect the chain of custody for the relevant exhibits.
After addressing chain of custody, the court turned to the elements of the offence. Possession under the MDA can be actual or constructive, and it may be inferred from circumstances such as proximity, control, and the accused’s conduct. The court had to decide whether Iswan’s possession was established in relation to the seized drug exhibits in the car. The fact that Iswan informed officers that drugs were in his car, and that the drugs were found in locations within the car, were likely central to the court’s inference of possession.
Knowledge of the nature of the drugs is another essential element. The court would have assessed Iswan’s statements and conduct, including whether he demonstrated awareness that the substances were drugs. The judgment’s outline indicates that Iswan had shifting versions of events. Shifting accounts can affect credibility and may support an inference that the accused’s knowledge was not consistent with innocence. The court also considered whether Iswan’s “bailee” defence could negate knowledge or purpose. The outline suggests that the court did not accept a complete bailee defence, because it addressed two sub-issues: whether Iswan was involved in the sale of certain exhibits to Zahari, and whether Iswan knew the exhibits were meant to be passed on to other persons.
On trafficking, the statutory presumption of trafficking typically arises where the accused is found in possession of controlled drugs above certain thresholds. Once the presumption applies, the burden shifts to the accused to rebut it on a balance of probabilities, usually by adducing evidence consistent with consumption or other non-trafficking purposes. The court’s outline indicates that it considered whether the defence of consumption applied to Exhibits C1A and C1B. This suggests that the court treated the accused’s rebuttal attempt as potentially exhibit-specific, rather than uniformly applicable to all exhibits.
Finally, the court’s reasoning would have integrated the evidential picture: the chain of custody, the forensic findings confirming diamorphine content, and the accused’s knowledge and purpose. The court’s structured approach indicates that it evaluated each exhibit and each defence component rather than relying on a single general inference.
What Was the Outcome?
Based on the judgment’s focus on whether the prosecution established chain of custody and whether the elements of the MDA charge were made out, the court’s final determination would have depended on whether any identified gaps—such as the omission of Exhibit J1A1 or weight discrepancies—created reasonable doubt as to the integrity of the diamorphine exhibits. The outline indicates that the court reached conclusions on possession, knowledge, and trafficking presumption, as well as on the partial applicability of a consumption defence.
Accordingly, the practical effect of the outcome was that the court either convicted Iswan on the trafficking charge or acquitted him if the prosecution failed to prove one or more essential elements beyond reasonable doubt. The judgment’s detailed treatment of each evidential issue reflects the High Court’s careful application of the MDA’s strict evidential requirements in drug prosecutions.
Why Does This Case Matter?
This case is significant for practitioners because it illustrates the High Court’s methodical approach to chain-of-custody challenges in MDA prosecutions. Defence counsel often attacks custody at multiple points—seizure, packing, transfers, locked storage, weighing, sealing, and laboratory analysis. The judgment’s explicit identification of issues such as removal and delivery from a locked cabinet, weight differences, and omission of an exhibit underscores that courts will scrutinise both the factual timeline and the procedural safeguards that protect evidential integrity.
Substantively, the case also matters for how courts evaluate “bailee” and related rebuttal narratives. Where an accused claims involvement in sale or delivery but denies trafficking intent, the court will examine whether the accused knew the drugs were meant to be passed on and whether the accused’s account is credible in light of contemporaneous statements and trial evidence. The judgment’s exhibit-specific analysis of whether consumption could apply to certain packets demonstrates that rebuttal is not necessarily an all-or-nothing proposition.
For law students and lawyers, the decision provides a useful template for structuring submissions: first, isolate chain-of-custody weaknesses; second, assess possession and knowledge; third, address the statutory presumption and rebuttal evidence; and fourth, evaluate credibility and consistency across statements. Even without the full text reproduced here, the judgment outline shows that the court’s reasoning is organised around these doctrinal pillars.
Legislation Referenced
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 2 (definition of “traffic”); s 5(1)(a); s 5(2) [CDN] [SSO]
- Criminal Procedure Code (Cap 68, 2012 Rev Ed), s 22 (statements by accused during investigations) [CDN] [SSO]
- Criminal Procedure Code (Cap 68, 2012 Rev Ed), s 23 (cautioned statements) (noted as recorded for stood down charges) [CDN] [SSO]
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed), s 16 (certificates by analysts/forensic analysis) (as referenced in the HSA certificates) [CDN] [SSO]
Cases Cited
- [2009] SGHC 202
- [2024] SGHC 239
- Muhammad Ridzuan bin Md Ali v Public Prosecutor and other matters [2014] 3 SLR 721
Source Documents
This article analyses [2024] SGHC 239 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.